Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Ok

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Apr 22, 2024 1:30pm

48 Views

Post# 36001633

RE:RE:Ok

Where in my previous post did I mention 5B? I'm not in the know on a buyout price.... and neither is anyone on here. The pumpers just like to speculate. The pumpers just post worthless information and show their ignorance.

<< Previous

Bullboard Posts

Next >>

Maximizing savings: Exploring 5 cash-back and promo deal apps